Ana Angulo-Urarte

Ana Angulo-Urarte

Auto-generated profile, based on publicly available information

Ana Angulo-Urarte

Amsterdam UMC, Amsterdam Cardiovascular Sciences, University of Amsterdam 1 Department of Medical Biochemistry Amsterdam

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2016 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
SCSandra D. Castillo
Sandra D. Castillo
ETElena Tzouanacou
Elena Tzouanacou
MZMay Zaw-Thin
May Zaw-Thin
IBInma M. Berenjeno
Inma M. Berenjeno
VPVictoria E.R. Parker
Victoria E.R. Parker
BVBart Vanhaesebroeck
Bart Vanhaesebroeck
Mutant Pik3ca gives rise to venous malformations.

29 November 2016 in Nature Communications
Verified
Journal Article
Open access
PDF file
RORoxana Ola
Roxana Ola
ADAlexandre Dubrac
Alexandre Dubrac
JHJinah Han
Jinah Han
FZFeng Zhang
Feng Zhang
JFJennifer S Fang
Jennifer S Fang
AEAnne Eichmann
Anne Eichmann
Activin receptor-like kinase 1 (ALK1) is an endothelial serine–threonine kinase receptor for bone morphogenetic proteins (BMPs) 9 and 10. Inactivating mutations in the ALK1 gene cause hereditary haemorrhagic telangiectasia type 2 (HHT2), a disabling disease characterized by excessive angiogenesis with arteriovenous malformations (AVMs). Here we show that inducible, endothelial-specific homozygous Alk1 inactivation and BMP9/10 ligand blockade both lead to AVM formation in postnatal retinal vessels and internal organs including the gastrointestinal (GI) tract in mice. VEGF and PI3K/AKT signalling are increased on Alk1 deletion and BMP9/10 ligand blockade. Genetic deletion of the signal-transducing Vegfr2 receptor prevents excessive angiogenesis but does not fully revert AVM formation. In contrast, pharmacological PI3K inhibition efficiently prevents AVM formation and reverts established AVMs. Thus, Alk1 deletion leads to increased endothelial PI3K pathway activation that may be a novel target for the treatment of vascular lesions in HHT2.

1 September 2020 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Open access
AAAna Angulo-Urarte
Ana Angulo-Urarte
TWTanne van der Wal
Tanne van der Wal
SHStephan Huveneers
Stephan Huveneers
Epithelial and endothelial monolayers are multicellular sheets that form barriers between the 'outside' and 'inside' of tissues. Cell-cell junctions, made by adherens junctions, tight junctions and desmosomes, hold together these monolayers. They form intercellular contacts by binding their receptor counterparts on neighboring cells and anchoring these structures intracellularly to the cytoskeleton. During tissue development, maintenance and pathogenesis, monolayers encounter a range of mechanical forces from the cells themselves and from external systemic forces, such as blood pressure or tissue stiffness. The molecular landscape of cell-cell junctions is diverse, containing transmembrane proteins that form intercellular bonds and a variety of cytoplasmic proteins that remodel the junctional connection to the cytoskeleton. Many junction-associated proteins participate in mechanotransduction cascades to confer mechanical cues into cellular responses that allow monolayers to maintain their structural integrity. We will discuss force-dependent junctional molecular events and their role in cell-cell contact organization and remodeling.

31 July 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
HSHelena Serra
Helena Serra
ICIñigo Chivite
Iñigo Chivite
AAAna Angulo-Urarte
Ana Angulo-Urarte
ASAdriana Soler
Adriana Soler
JSJames D. Sutherland
James D. Sutherland
MGMariona Graupera
Mariona Graupera
Coordinated activity of VEGF and Notch signals guides the endothelial cell (EC) specification into tip and stalk cells during angiogenesis. Notch activation in stalk cells leads to proliferation arrest via an unknown mechanism. By using gain- and loss-of-function gene-targeting approaches, here we show that PTEN is crucial for blocking stalk cell proliferation downstream of Notch, and this is critical for mouse vessel development. Endothelial deletion of PTEN results in vascular hyperplasia due to a failure to mediate Notch-induced proliferation arrest. Conversely, overexpression of PTEN reduces vascular density and abrogates the increase in EC proliferation induced by Notch blockade. PTEN is a lipid/protein phosphatase that also has nuclear phosphatase-independent functions. We show that both the catalytic and non-catalytic APC/C-Fzr1/Cdh1-mediated activities of PTEN are required for stalk cells’ proliferative arrest. These findings define a Notch–PTEN signalling axis as an orchestrator of vessel density and implicate the PTEN-APC/C-Fzr1/Cdh1 hub in angiogenesis.

1 April 2016 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
VCVittorio Calderone
Vittorio Calderone
JGJavier Gallego
Javier Gallego
GFGonzalo Fernandez-Miranda
Gonzalo Fernandez-Miranda
EGEster Garcia-Pras
Ester Garcia-Pras
CMCarlos Maillo
Carlos Maillo
RMRaul Mendez
Raul Mendez

16 November 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
AAAna Angulo-Urarte
Ana Angulo-Urarte
PCPedro Casado
Pedro Casado
SCSandra D. Castillo
Sandra D. Castillo
PKPiotr Kobialka
Piotr Kobialka
MKMaria Paraskevi Kotini
Maria Paraskevi Kotini
MGMariona Graupera
Mariona Graupera
Angiogenesis is a dynamic process relying on endothelial cell rearrangements within vascular tubes, yet the underlying mechanisms and functional relevance are poorly understood. Here we show that PI3Kα regulates endothelial cell rearrangements using a combination of a PI3Kα-selective inhibitor and endothelial-specific genetic deletion to abrogate PI3Kα activity during vessel development. Quantitative phosphoproteomics together with detailed cell biology analyses in vivo and in vitro reveal that PI3K signalling prevents NUAK1-dependent phosphorylation of the myosin phosphatase targeting-1 (MYPT1) protein, thereby allowing myosin light chain phosphatase (MLCP) activity and ultimately downregulating actomyosin contractility. Decreased PI3K activity enhances actomyosin contractility and impairs junctional remodelling and stabilization. This leads to overstretched endothelial cells that fail to anastomose properly and form aberrant superimposed layers within the vasculature. Our findings define the PI3K/NUAK1/MYPT1/MLCP axis as a critical pathway to regulate actomyosin contractility in endothelial cells, supporting vascular patterning and expansion through the control of cell rearrangement.